Clinical Study

Continuous Aspiration Thrombectomy in High- and Intermediate-High-Risk Pulmonary Embolism in Real-World Clinical Practice

Table 1

Detailed clinical and outcomes characteristics.

VariablesN = 14

Male/female6/8
Age (years)56 (44–65)
Body mass index (kg/m2)26.8 (23.9–29.7)
Comorbidities
 Arterial hypertension5 (35.7%)
 Diabetes mellitus2 (14.3%)
 Obesity8 (57.1%)
 Coronary artery disease0 (0%)
 Chronic obstructive pulmonary disease1 (7.1%)
 Charlson Comorbidity Index2 (1–3)
 Smoking2 (14.3%)
Risk factors of PE
 Contraceptives0 (0%)
 Immobilization/surgery during last 14 days8 (57.1%)
 Malignancy4 (28.6%)
 Prior PE or DVT0 (0%)
Clinical presentation
 Shock3 (21.4%)
 Syncope or presyncope5 (35.7%)
 Cardiac arrest2 (14.3%)
 Respiratory failure (desaturation <92%)8 (57.1%)
 Dyspnea12 (85.7%)
 Chest pain1 (7.1%)
 DVT at presentation9 (64.2%)
 HR (per min)110 (100–120)
 Respiratory rate (per min)32.5 (30–34)
 SBP (mmHg)106 (90–127)
 DBP (mmHg)73.5 (59–87.5)
Laboratory findings
 Troponin I positive at presentation14 (100%)
 Troponin I concentration (ng/ml)59.4 (0.29–64.5)
 D-dimers concentration (ng/ml)11900 (4244–17185)
 NT-proBNP concentration (pg/ml)3993.5 (2457–47670)
Echocardiographic findings (4CH)
 RV diameter (mm)46 (44–46)
 LV diameter (mm)34 (32–26)
 RV/LV ratio (mm)1.3 (1.3–1.5)
 TAPSE (mm)16 (13–19)
 LV ejection fraction55 (50–55)
 RV systolic pressure60 (42–62)
 In-hospital death1 (7.1%)
 Death of RV insufficiency0 (0%)
 Death during follow-up2 (14.3%)
 Minor bleeding2 (14.3%)
 Major bleeding0

Values are median (IQR) or n (%); 4CH = four chamber view, DBP = diastolic blood pressure, DVT = deep vein thrombosis, HR = heart rate, PE = pulmonary embolism, NT-proBNP = N-terminal pro-B-type natriuretic peptide, LV = left ventricle, RV = right ventricle, SBP = systolic blood pressure, and TAPSE = tricuspid annular plane systolic excursion.